Why We're MADE FOR THIS
Learn what we're doing to transform health care, prepare the next generation of leaders, and solve the world's greatest medical challenges.
Stories
A Legacy of Discovery: Dr. Michael Hershfield’s Gift to Fuel the Next Generation of Translational Research
Professor of Medicine Michael Hershfield's research has transformed the lives of patients with rare immunodeficiencies and treatment-resistant gout. Now he's made a philanthropic gift to support early career physician-scientists at Duke.
The Duke Mouse Brain Atlas Promises to Accelerate Studies of Neurological Disorders
A new, high-resolution atlas of the mouse brain will increase precision in measuring changes in brain structure and make it easier to share results for scientists working to understand neurological diseases such as Alzheimer's.
Honey, I Shrunk the Proteins
A Duke University School of Medicine team reimagines a sci-fi classic as real-world biotech that can speed up biological research.
Neuroscientists Develop An AI Tool to Reveal the Brain's Secrets
An epic collaboration between neuroscientists at Duke and six other institutions has yielded an AI tool that paves the way for new approaches to treating neurological disorders.
Scientists Hack Cell Entry to Supercharge Cancer Drugs
New strategy could change how we design drugs—especially the large and polar ones that were once too big to work.
Advancing Prenatal, Postnatal Care Through Early Genetic Insight
Researchers propose a "treatable fetal findings list" that identifies genetic conditions that can be detected with prenatal testing and treated in utero or in the first week of life.
After a Brain Tumor Diagnosis Came Hope
Sabrina Lewandowski was diagnosed with a usually fatal form of glioblastoma that many centers would have considered untreatable. But the research-intensive team at Duke took a different approach — and 23 years later, she's living her life and raising her 13-year-old daughter.
The Fungal Fallout of Climate Disasters
When Hurricane Helene hit Western North Carolina, it left more than flood damage—it fostered mold and fungal growth. Now, a Duke University team is studying how post-disaster fungi could affect health and recovery in a warming world.
How Duke Research Turned Failure Into Hope for Patients With Breast Cancer
The discovery in the lab of Duke cancer pharmacologist Donald McDonnell of a new drug treatment has changed the lives of thousands of patients of a type of breast cancer. The decade-long research behind the drug is exemplary of the benefits of the historical partnership between the federal government and universities in supporting biomedical research. It also shows the singular role universities play in developing treatments that can be brought to market.
Duke University School of Nursing Receives $4.1 Million Estate Gift from Dean Emerita Ruby L. Wilson
Dean Emerita Wilson’s gift will fund an international visiting professorship and Duke’s Center for Nursing Research, to be renamed in her honor.